| - GRCh37:
- Chr2:241813394
- GRCh38:
- Chr2:240873977
| AGXT | | Primary hyperoxaluria, type I | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:241817041
- GRCh38:
- Chr2:240877624
| AGXT | K190*, K312* | Primary hyperoxaluria, type I | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808679
- GRCh38:
- Chr2:240869262
| AGXT | E87fs | Primary hyperoxaluria, type I | Likely pathogenic (Dec 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241814551
- GRCh38:
- Chr2:240875134
| AGXT | K236* | Primary hyperoxaluria, type I | Likely pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808700
- GRCh38:
- Chr2:240869283
| AGXT | L94fs | Primary hyperoxaluria, type I | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808657-241808669
- GRCh38:
- Chr2:240869240-240869252
| AGXT | G80fs | Primary hyperoxaluria, type I | Likely pathogenic (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241812407
- GRCh38:
- Chr2:240872990
| AGXT | L179fs | Primary hyperoxaluria, type I | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241812399
- GRCh38:
- Chr2:240872982
| AGXT | Y176* | Primary hyperoxaluria, type I | Likely pathogenic (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241812449-241812450
- GRCh38:
- Chr2:240873032-240873033
| AGXT | Y194fs | Primary hyperoxaluria, type I | Likely pathogenic (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808313-241808314
- GRCh38:
- Chr2:240868896-240868897
| AGXT | P11fs | Primary hyperoxaluria, type I | Likely pathogenic (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810137
- GRCh38:
- Chr2:240870720
| AGXT | | not provided, Primary hyperoxaluria, type I | Likely benign (May 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241810825
- GRCh38:
- Chr2:240871408
| AGXT | | not provided, Primary hyperoxaluria, type I | Likely benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241817561
- GRCh38:
- Chr2:240878144
| AGXT | | not provided, Primary hyperoxaluria, type I | Conflicting interpretations of pathogenicity (Sep 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241817498
- GRCh38:
- Chr2:240878081
| AGXT | | not provided, Primary hyperoxaluria, type I | Likely benign (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241813441
- GRCh38:
- Chr2:240874024
| AGXT | P215fs | Primary hyperoxaluria, type I | Pathogenic (Aug 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241815413
- GRCh38:
- Chr2:240875996
| AGXT | A280fs | Primary hyperoxaluria, type I | Likely pathogenic (Oct 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808726
- GRCh38:
- Chr2:240869309
| AGXT | V102D | Primary hyperoxaluria, type I | Likely pathogenic (Oct 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241817176
- GRCh38:
- Chr2:240877759
| AGXT | | not provided, Primary hyperoxaluria, type I | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241816871
- GRCh38:
- Chr2:240877454
| AGXT | | not provided, Primary hyperoxaluria, type I | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241815620
- GRCh38:
- Chr2:240876203
| AGXT | | not provided, Primary hyperoxaluria, type I | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241815591
- GRCh38:
- Chr2:240876174
| AGXT | | not provided, Primary hyperoxaluria, type I | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241812566
- GRCh38:
- Chr2:240873149
| AGXT | | Primary hyperoxaluria, type I, not provided | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241808942
- GRCh38:
- Chr2:240869525
| AGXT | | Primary hyperoxaluria, type I, not provided | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241813459
- GRCh38:
- Chr2:240874042
| AGXT | | Primary hyperoxaluria, type I, not provided | Likely benign (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241810792
- GRCh38:
- Chr2:240871375
| AGXT | | not provided | Likely benign (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808309
- GRCh38:
- Chr2:240868892
| AGXT | | not provided, Primary hyperoxaluria, type I | Likely benign (Sep 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241818229
- GRCh38:
- Chr2:240878812
| AGXT | | not provided | Likely benign (Oct 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241813385
- GRCh38:
- Chr2:240873968
| AGXT | | not provided, Primary hyperoxaluria, type I | Likely benign (Jan 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241813388
- GRCh38:
- Chr2:240873971
| AGXT | | Primary hyperoxaluria, type I, not provided | Likely benign (Oct 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241817477
- GRCh38:
- Chr2:240878060
| AGXT | | not provided, Primary hyperoxaluria, type I | Likely benign (May 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241813436
- GRCh38:
- Chr2:240874019
| AGXT | A213T | not provided, Primary hyperoxaluria, type I | Uncertain significance (Jan 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241816989
- GRCh38:
- Chr2:240877572
| AGXT | | not provided | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241815426
- GRCh38:
- Chr2:240876009
| AGXT | | Primary hyperoxaluria, type I | Uncertain significance (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241812422
- GRCh38:
- Chr2:240873005
| AGXT | S184L | Primary hyperoxaluria, type I | Uncertain significance (Jan 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808762
- GRCh38:
- Chr2:240869345
| AGXT | D114G | Primary hyperoxaluria, type I | Uncertain significance (Aug 14, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:241813452
- GRCh38:
- Chr2:240874035
| AGXT | S218* | Primary hyperoxaluria, type I | Likely pathogenic (Feb 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810781
- GRCh38:
- Chr2:240871364
| AGXT | K147* | Primary hyperoxaluria, type I | Likely pathogenic (Dec 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810114
- GRCh38:
- Chr2:240870697
| AGXT | E138* | Primary hyperoxaluria, type I | Likely pathogenic (Oct 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808779
- GRCh38:
- Chr2:240869362
| AGXT | G120* | Primary hyperoxaluria, type I | Likely pathogenic (Dec 16, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808673
- GRCh38:
- Chr2:240869256
| AGXT | C84* | Primary hyperoxaluria, type I | Likely pathogenic (May 31, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808619
- GRCh38:
- Chr2:240869202
| AGXT | Y66* | Primary hyperoxaluria, type I | Pathogenic/Likely pathogenic (Nov 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241812405
- GRCh38:
- Chr2:240872988
| AGXT | C178W | Primary hyperoxaluria, type I | Likely pathogenic (Jul 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810073-241810080
- GRCh38:
- Chr2:240870656-240870663
| AGXT | P125fs | Primary hyperoxaluria, type I, not provided | Pathogenic/Likely pathogenic (Dec 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241808707
- GRCh38:
- Chr2:240869290
| AGXT | P96A | not provided, Primary hyperoxaluria, type I | Uncertain significance (Mar 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241808779
- GRCh38:
- Chr2:240869362
| AGXT | G120R | not provided, Primary hyperoxaluria, type I | Uncertain significance (Mar 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241808352
- GRCh38:
- Chr2:240868935
| AGXT | L24I | Primary hyperoxaluria, type I, not provided | Uncertain significance (Nov 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241817468
- GRCh38:
- Chr2:240878051
| AGXT | A325fs | not provided, Primary hyperoxaluria, type I | Pathogenic/Likely pathogenic (Aug 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241808593
- GRCh38:
- Chr2:240869176
| AGXT | D58N | not provided | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810852
- GRCh38:
- Chr2:240871435
| AGXT | | Primary hyperoxaluria, type I, not provided | Conflicting interpretations of pathogenicity (Sep 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241818523
- GRCh38:
- Chr2:240879106
| AGXT | | Primary hyperoxaluria, type I | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241818432
- GRCh38:
- Chr2:240879015
| AGXT | | Primary hyperoxaluria, type I | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241818290
- GRCh38:
- Chr2:240878873
| AGXT | | Primary hyperoxaluria, type I | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810833
- GRCh38:
- Chr2:240871416
| AGXT | Q164L | Primary hyperoxaluria, type I | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808635
- GRCh38:
- Chr2:240869218
| AGXT | N72H | not provided, Primary hyperoxaluria, type I | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241808595
- GRCh38:
- Chr2:240869178
| AGXT | D58E | Primary hyperoxaluria, type I | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241817561
- GRCh38:
- Chr2:240878144
| AGXT | | not provided, Primary hyperoxaluria, type I | Conflicting interpretations of pathogenicity (Oct 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241817542
- GRCh38:
- Chr2:240878125
| AGXT | G349D | Primary hyperoxaluria, type I | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241817515
- GRCh38:
- Chr2:240878098
| AGXT | I340T | Primary hyperoxaluria, type I | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241817446
- GRCh38:
- Chr2:240878029
| AGXT | R317Q | Primary hyperoxaluria, type I | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241817061
- GRCh38:
- Chr2:240877644
| AGXT | | not provided, Primary hyperoxaluria, type I | Benign/Likely benign (Jul 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241808322
- GRCh38:
- Chr2:240868905
| AGXT | | not provided, Primary hyperoxaluria, type I | Conflicting interpretations of pathogenicity (Apr 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241808313
- GRCh38:
- Chr2:240868896
| AGXT | P11A | Primary hyperoxaluria, type I | Uncertain significance (Apr 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241808259
- GRCh38:
- Chr2:240868842
| AGXT | | Primary hyperoxaluria, type I | Likely benign (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241817049
- GRCh38:
- Chr2:240877632
| AGXT | | not provided | Uncertain significance (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241814527-241814529
- GRCh38:
- Chr2:240875110-240875112
| AGXT | K229del | Primary hyperoxaluria, type I | Likely pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810077
- GRCh38:
- Chr2:240870660
| AGXT | | Primary hyperoxaluria, type I, not provided | Likely benign (Jun 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241814607
- GRCh38:
- Chr2:240875190
| AGXT | | not provided | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241815415
- GRCh38:
- Chr2:240875998
| AGXT | | not provided | Likely benign (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241816995
- GRCh38:
- Chr2:240877578
| AGXT | | not provided, Primary hyperoxaluria, type I | Likely benign (Aug 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241816992
- GRCh38:
- Chr2:240877575
| AGXT | | Primary hyperoxaluria, type I, not provided | Conflicting interpretations of pathogenicity (Oct 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241812408
- GRCh38:
- Chr2:240872991
| AGXT | | not provided, Primary hyperoxaluria, type I | Conflicting interpretations of pathogenicity (Nov 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241816983
- GRCh38:
- Chr2:240877566
| AGXT | | not provided | Likely benign (Oct 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241815380
- GRCh38:
- Chr2:240875963
| AGXT | | not provided | Benign (Oct 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241812438
- GRCh38:
- Chr2:240873021
| AGXT | | not provided, Primary hyperoxaluria, type I | Conflicting interpretations of pathogenicity (Oct 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241815370
- GRCh38:
- Chr2:240875953
| AGXT | | not provided | Likely benign (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241812444
- GRCh38:
- Chr2:240873027
| AGXT | | not provided, Primary hyperoxaluria, type I | Benign/Likely benign (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241817519
- GRCh38:
- Chr2:240878102
| AGXT | D341E | Primary hyperoxaluria, type I, not provided | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241810762
- GRCh38:
- Chr2:240871345
| AGXT | | Primary hyperoxaluria, type I, not provided | Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241817445
- GRCh38:
- Chr2:240878028
| AGXT | R317W | Primary hyperoxaluria, type I, not provided | Conflicting interpretations of pathogenicity (Jul 13, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241810126
- GRCh38:
- Chr2:240870709
| AGXT | | Primary hyperoxaluria, type I | Likely pathogenic (May 25, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241816952-241816953
- GRCh38:
- Chr2:240877535-240877536
| AGXT | | Primary hyperoxaluria, type I | Likely pathogenic (May 24, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810105-241810106
- GRCh38:
- Chr2:240870688-240870689
| AGXT | Q137fs | Primary hyperoxaluria, type I | Pathogenic (Mar 21, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241814526-241814527
- GRCh38:
- Chr2:240875109-240875110
| AGXT | | Primary hyperoxaluria, type I | Uncertain significance (Feb 20, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241815356
- GRCh38:
- Chr2:240875939
| AGXT | H261D | not provided, Primary hyperoxaluria, type I | Conflicting interpretations of pathogenicity (Jun 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241808364
- GRCh38:
- Chr2:240868947
| AGXT | P28S | Primary hyperoxaluria, type I | Uncertain significance (Feb 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241808402-241808403
- GRCh38:
- Chr2:240868985-240868986
| AGXT | L43fs | Primary hyperoxaluria, type I | Likely pathogenic (Oct 16, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810125
- GRCh38:
- Chr2:240870708
| AGXT | E141D | Primary hyperoxaluria, type I | Uncertain significance (Aug 16, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810808
- GRCh38:
- Chr2:240871391
| AGXT | G156R | not provided, Primary hyperoxaluria, type I | Pathogenic (Dec 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241818277
- GRCh38:
- Chr2:240878860
| AGXT | | Primary hyperoxaluria, type I | Uncertain significance (Apr 24, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241810868
- GRCh38:
- Chr2:240871451
| AGXT | | Primary hyperoxaluria, type I | Likely pathogenic (Apr 6, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241808674-241808685
- GRCh38:
- Chr2:240869257-240869268
| AGXT | | not provided, Primary hyperoxaluria, type I | Uncertain significance (May 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241814525
- GRCh38:
- Chr2:240875108
| AGXT | | Primary hyperoxaluria, type I | Likely pathogenic (Mar 29, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241814623
- GRCh38:
- Chr2:240875206
| AGXT | | Primary hyperoxaluria, type I | Likely pathogenic (Feb 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241815335
- GRCh38:
- Chr2:240875918
| AGXT | | not provided, Primary hyperoxaluria, type I | Likely benign (Sep 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241808427
- GRCh38:
- Chr2:240869010
| AGXT | M49L | not provided, Primary hyperoxaluria, type I, not specified
| Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241813475
- GRCh38:
- Chr2:240874058
| AGXT | A226T | not provided | Uncertain significance (Aug 22, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241814588
- GRCh38:
- Chr2:240875171
| AGXT | A248V | not provided, Primary hyperoxaluria, type I, Inborn genetic diseases
| Conflicting interpretations of pathogenicity (Mar 29, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:241808310
- GRCh38:
- Chr2:240868893
| AGXT | P10A | not provided | Uncertain significance (Feb 13, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:241813472-241813475
- GRCh38:
- Chr2:240874055-240874058
| AGXT | K225fs | Primary hyperoxaluria, type I, not provided | Pathogenic/Likely pathogenic (Apr 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:241818400
- GRCh38:
- Chr2:240878983
| AGXT | | Primary hyperoxaluria, type I | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |